Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study-Reference-Cited by-同舟云学术

Ranibizumab for the treatment of choroidal neovascularisation secondary to pathological myopia: interim analysis of the REPAIR study

Published:2013-03-01 Issue:6 Volume:27 Page:709-715
ISSN:0950-222X
Container-title:Eye
language:en
Short-container-title:Eye

Author:

Tufail A,Patel P J,Sivaprasad S,Amoaku W,Browning A C,Cole M,Gale R,George S,Lotery A J,Majid M,McKibbin M,Menon G,Yang Y,Andrews C,Brittain C,Osborne A

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://www.nature.com/articles/eye20138.pdf

Reference22 articles.

1. Montero JA, Ruiz-Moreno JM . Treatment of choroidal neovascularization in high myopia. Curr Drug Targets 2010; 11 (5): 630–644.

2. Soubrane G . Choroidal neovascularization in pathologic myopia: recent developments in diagnosis and treatment. Surv Ophthalmol 2008; 53 (2): 121–138.

3. Chan WM, Ohji M, Lai TYY, Liu DTL, Tano Y, Lam DSC . Choroidal neovascularisation in pathological myopia: an update in management. Br J Ophthalmol 2005; 89 (11): 1522–1528.

4. Battaglia Parodi M, Iacono P, Bandello F . Antivascular endothelial growth factor for choroidal neovascularization in pathologic myopia. Dev Ophthalmol 2010; 46: 73–83.

5. Cohen SY . Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina 2009; 29 (8): 1062–1066.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ten-year outcomes of intravitreal injection of ranibizumab for the treatment of myopic choroidal neovascularization: a retrospective study;2023-09-01

2. Efficacy and safety of different conbercept injection regimens in the treatment of choroidal neovascularization in pathological myopia: a retrospective study;International Ophthalmology;2023-07-31

3. Long-term Outcomes of Myopic Choroidal Neovascularization and Retinal Changes according to ATN Classification;Journal of the Korean Ophthalmological Society;2023-06-15

4. Comparison of the outcome of limited protocol Ranibizumab injection in naïve choroidal neovascular membranes secondary to pathological myopia versus age-related macular degeneration;Journal of the Egyptian Ophthalmological Society;2023

5. A systematic review of clinical practice guidelines for myopic macular degeneration;Journal of Global Health;2022-03-26